Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Sell
C
Homology Medicines, Inc. Common Stock (FIXX)
Pharmaceutical Preparations
https://www.homologymedicines.com
Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
ONE PATRIOTS PARK
BEDFORD, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
03/28/2018
Market Cap
3,018,745
Shares Outstanding
57,930,000
Weighted SO
58,017,412
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
-0.1070
Last Div
0.0000
Range
0.9-26.64
Chg
0.0071
Avg Vol
29535
Mkt Cap
3018745
Exch
NASDAQ
Country
US
Phone
781 301 7277
DCF Diff
1.2774
DCF
-0.3427
Div Yield
0.0000
P/S
1.7036
EV Multiple
1.2032
P/FV
0.0191
Div Yield %
0.0000
P/E
-0.0112
PEG
-0.0058
Payout
0.0000
Current Ratio
4.1891
Quick Ratio
4.1062
Cash Ratio
3.5053
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
911.1223
CCC
-911.1223
Gross Margin
-0.1213
Op Margin
-48.5745
Pretax Margin
-33.7658
Net Margin
-46.8894
Eff Tax Rate
-0.3887
ROA
-0.5454
ROE
-1.0091
ROCE
-0.7210
NI/EBT
1.3887
EBT/EBIT
0.6951
EBIT/Rev
-48.5745
Debt Ratio
0.0603
D/E
0.1884
LT Debt/Cap
0.1112
Total Debt/Cap
0.1585
Int Coverage
-58.5936
CF/Debt
-9.2225
Equity Multi
3.1236
Rec Turnover
0.0000
Pay Turnover
0.4006
Inv Turnover
0.0000
FA Turnover
0.2266
Asset Turnover
0.0116
OCF/Share
-85.1288
FCF/Share
-85.1288
Cash/Share
135.9537
OCF/Sales
-47.8143
FCF/OCF
1.0000
CF Coverage
-9.2225
ST Coverage
-27.4375
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
0.0191
P/B
0.0191
P/S
1.7036
P/E
-0.0112
P/FCF
-0.0356
P/OCF
-0.0110
P/CF
-0.0110
PEG
-0.0058
P/S
1.7036
EV Multiple
1.2032
P/FV
0.0191
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | XXXXXX | ▲ 1.42M | ▼ 0.00 |
Cost Of Revenue | X | X | X | X | ▲ XXXXXX | ▲ 1.29M | ▼ 0.00 |
Gross Profit | XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 131.00K | ▼ 0.00 |
Gross Profit Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▼ 0.09 | ▼ 0.00 |
Research And Development Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 1.51M | ▲ 9.84M |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ 7.90M | ▼ 5.00M |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ 7.90M | ▼ 5.00M |
Other Expenses | X | X | X | X | X | ▲ 2.69M | ▼ 0.00 |
Operating Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 9.41M | ▲ 14.84M |
Cost And Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 9.41M | ▲ 14.84M |
Interest Income | XXXXXXX | ▲ XXXXXXX | ▼ XXXXX | ▲ XXXXX | ▲ XXXXXXX | ▼ 1.18M | ▼ 0.00 |
Interest Expense | X | X | X | X | ▼ -XXXXXXX | ▲ 1.47M | ▼ 0.00 |
Depreciation And Amortization | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ -578.00K | ▲ 0.00 |
Ebitda | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -9.41M | ▼ -14.84M |
Ebitda Ratio | -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -6.64 | ▲ 0.00 |
Operating Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -9.41M | ▼ -14.84M |
Operating Income Ratio | -XX.XXXXXXXXX | ▼ -XX.XXXXXXXXX | ▲ -XX.XXXXXXXXX | ▼ -XX.XXXXXXXXX | ▼ -XX.XXXXXXXXX | ▲ -6.64 | ▲ 0.00 |
Total Other Income Expenses Net | XXXXXXX | ▲ XXXXXXX | ▼ XXXXX | ▲ XXXXX | ▲ XXXXXXX | ▲ 7.26M | ▲ 16.05M |
Income Before Tax | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -2.16M | ▲ 1.21M |
Income Before Tax Ratio | -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -XX.XXXXXXXXXX | ▲ -1.52 | ▲ 0.00 |
Income Tax Expense | X | X | X | X | ▼ -XXXXXX | ▲ 13.96M | ▼ 176.00K |
Net Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -16.12M | ▲ 1.03M |
Net Income Ratio | -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -XX.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▲ -XX.XXXXXXXXXX | ▲ -11.37 | ▲ 0.00 |
Eps | -XX.XX | ▼ -XX.XX | ▼ -XXX.XX | ▲ -XXX.XX | ▲ -XXX.XX | ▲ -50.01 | ▲ 1.03 |
Eps Diluted | -XX.XX | ▼ -XX.XX | ▼ -XXX.XX | ▲ -XXX.XX | ▲ -XXX.XX | ▲ -50.01 | ▲ 0.44 |
Weighted Average Shs Out | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ 322.32K | ▲ 995.28K |
Weighted Average Shs Out Dil | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ 322.32K | ▲ 2.33M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXX | ▲ 39.27M | ▲ 115.51M |
Short Term Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▼ X | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ 43.39M | ▼ 19.80M |
Cash And Short Term Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 82.65M | ▲ 135.31M |
Net Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Other Current Assets | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 1.26M | ▲ 2.73M |
Total Current Assets | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 83.91M | ▲ 138.04M |
Property Plant Equipment Net | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ 650.00K | ▲ 7.82M |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Goodwill And Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Long Term Investments | X | X | X | X | ▲ XXXXXXXX | ▼ 0.00 | 0.00 |
Tax Assets | X | X | X | X | X | ▲ 221.56M | ▼ 0.00 |
Other Non Current Assets | XXXXXXX | ▼ XXXXXXX | XXXXXXX | ▲ XXXXXXX | ▼ -XXXXXXXX | ▲ 0.00 | ▲ 6.47M |
Total Non Current Assets | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 222.21M | ▼ 14.29M |
Other Assets | X | X | X | X | X | 0.00 | 0.00 |
Total Assets | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 306.12M | ▼ 152.33M |
Account Payables | XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ 3.23M | ▲ 4.96M |
Short Term Debt | X | X | ▲ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 1.32M | ▲ 3.09M |
Tax Payables | X | X | X | X | X | 0.00 | 0.00 |
Deferred Revenue | XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ 0.00 | 0.00 |
Other Current Liabilities | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 7.02M | ▲ 24.91M |
Total Current Liabilities | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ 11.57M | ▲ 32.95M |
Long Term Debt | X | X | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 0.00 | ▲ 6.10M |
Deferred Revenue Non Current | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ X | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | X | X | ▼ -XXXXXXXX | ▲ X | X | ▲ 221.56M | ▼ 0.00 |
Other Non Current Liabilities | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ X | X | ▼ -1.00 | ▲ 64.51M |
Total Non Current Liabilities | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 221.55M | ▼ 70.61M |
Other Liabilities | X | X | X | X | X | ▲ 1.00 | ▼ 0.00 |
Capital Lease Obligations | X | X | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 1.32M | ▲ 6.10M |
Total Liabilities | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 233.13M | ▼ 103.57M |
Preferred Stock | X | X | X | X | X | 0.00 | ▲ 152.33M |
Common Stock | XXXX | ▲ XXXX | ▲ XXXX | ▲ XXXX | XXXX | 6.00K | ▼ 2.00K |
Retained Earnings | -XXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -542.10M | ▲ -186.05M |
Accumulated Other Comprehensive Income Loss | -XXXXX | ▲ XXXXXX | ▼ X | ▼ -XXXX | ▼ -XXXXXX | ▲ -5.00K | -5.00K |
Other Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 615.09M | ▼ 82.49M |
Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 72.99M | ▼ 48.77M |
Total Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 72.99M | ▼ 48.77M |
Total Liabilities And Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 306.12M | ▼ 152.33M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 306.12M | ▼ 152.33M |
Total Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▼ X | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ 43.39M | ▼ 19.80M |
Total Debt | X | X | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 1.32M | ▲ 9.19M |
Net Debt | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▼ -37.95M | ▼ -106.32M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -16.12M | ▲ 1.03M |
Depreciation And Amortization | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ 0.00 | ▲ 29.00K |
Deferred Income Tax | X | X | ▲ XXXXXX | ▼ XXXXXX | ▼ X | ▼ -7.80M | ▲ 0.00 |
Stock Based Compensation | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 847.00K | ▼ 417.00K |
Change In Working Capital | XXXXXXXX | ▼ -XXXXXXX | ▲ XXXXXXXX | ▼ -XXXXXXX | ▲ XXXXXXX | ▼ -11.54M | ▲ 0.00 |
Accounts Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Accounts Payables | XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -4.57M | ▲ 928.00K |
Other Working Capital | XXXXXXX | ▼ -XXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXXX | ▼ -6.98M | ▲ 0.00 |
Other Non Cash Items | -XXXXXXX | ▲ -XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ 5.24M | ▼ 0.00 |
Net Cash Provided By Operating Activities | -XXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -21.58M | ▲ -14.55M |
Investments In Property Plant And Equipment | -XXXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ -XXXX | ▲ 338.00K | ▼ 0.00 |
Acquisitions Net | X | X | X | X | ▼ -XXXXXXXXX | ▲ 216.00K | ▼ 0.00 |
Purchases Of Investments | -XXXXXXXX | ▼ -XXXXXXXX | ▲ XXXXX | ▼ -XXXX | ▲ X | 0.00 | 0.00 |
Sales Maturities Of Investments | XXXXXXXX | ▼ XXXXXXXX | ▼ X | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 31.50M | ▼ 97.00K |
Other Investing Activities | XXXXX | ▼ X | ▼ -XXXXX | ▲ X | ▲ XXXXXXXXX | ▼ -31.38M | ▲ 0.00 |
Net Cash Used For Investing Activities | XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 31.72M | ▼ 97.00K |
Debt Repayment | X | X | X | X | X | 0.00 | 0.00 |
Common Stock Issued | X | X | X | X | X | ▲ 14.00K | ▲ 42.00M |
Common Stock Repurchased | X | X | X | X | X | 0.00 | 0.00 |
Dividends Paid | X | X | X | X | X | 0.00 | 0.00 |
Other Financing Activities | XXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXX | ▲ XXXXX | ▼ 0.00 | ▲ 57.35M |
Net Cash Used Provided By Financing Activities | XXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXX | ▲ XXXXX | ▼ 14.00K | ▲ 99.35M |
Effect Of Forex Changes On Cash | XX | ▼ X | X | X | X | ▼ -14.73M | ▲ 0.00 |
Net Change In Cash | XXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ -XXXXXXX | ▲ 10.16M | ▲ 84.89M |
Cash At End Of Period | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXX | ▲ 39.27M | ▲ 116.16M |
Cash At Beginning Of Period | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 29.11M | ▲ 31.26M |
Operating Cash Flow | -XXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -21.58M | ▲ -14.55M |
Capital Expenditure | -XXXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ -XXXX | ▲ 338.00K | ▼ 0.00 |
Free Cash Flow | -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -21.24M | ▲ -14.55M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.